Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00293345
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Testing effectiveness (Phase 2)UnknownNCT00551122
What this trial is testing

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
University of Southampton 23
Early research (Phase 1)Study completedNCT02709226
What this trial is testing

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT01870726
What this trial is testing

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

Who this might be right for
c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM
Novartis Pharmaceuticals 43
Not applicableStudy completedNCT04988750
What this trial is testing

Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients

Who this might be right for
Recurrent GlioblastomaHigh-Grade Glioma (WHO III-IV)Brain Tumor Recurrent+3 more
NaviFUS Corporation 7
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Early research (Phase 1)Study completedNCT00045474
What this trial is testing

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00002986
What this trial is testing

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 36
Testing effectiveness (Phase 2)Looking for participantsNCT05588141
What this trial is testing

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Who this might be right for
Brain TumorCancer
National Cancer Institute (NCI) 96
Large-scale testing (Phase 3)Study completedNCT04305470
What this trial is testing

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

Who this might be right for
Meningioma
NX Development Corp 108
Testing effectiveness (Phase 2)Looking for participantsNCT07533942
What this trial is testing

JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Who this might be right for
Meningioma
Jazz Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00450866
What this trial is testing

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
David Peereboom, MD 55
Testing effectiveness (Phase 2)Study completedNCT00003731
What this trial is testing

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Study completedNCT00895622
What this trial is testing

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 244
Early research (Phase 1)Temporarily pausedNCT07353229
What this trial is testing

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Who this might be right for
High Risk MeningiomaRecurrent Meningioma
Thomas Jefferson University 24
Testing effectiveness (Phase 2)Looking for participantsNCT05681195
What this trial is testing

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Who this might be right for
Primary Central Nervous System LymphomaSecondary Central Nervous System LymphomaRelapsed Cancer+1 more
Baptist Health South Florida 15
Testing effectiveness (Phase 2)Ended earlyNCT01113463
What this trial is testing

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00275002
What this trial is testing

O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 41
Next Page